J. Litton

Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.

Yuan Qi, G. Mills, Y. Qi, 2019, JCO precision oncology.

Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes.

G. Mills, L. Strong, F. Meric-Bernstam, 2017, JCO precision oncology.

Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.

Ann M. Bailey, Yuan Qi, Y. Qi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.